410 ILCS 110/15
Department grant program
Illinois · Illinois Compiled Statutes 410 ILCS 110 — Stem Cell Research and Human Cloning Prohibition Act. · Status: effective
Cite this
- Citation
- 410 ILCS 110/15, Department grant program, Illinois, version 1 as recorded 2026-08-15, yourstate.us, https://yourstate.us/provision/1292345
- Permanent ID
ys:prov:1292345@1- SHA-256
ea46b2ce223f61d449958bb5c875bcb66165f0d20413432af186fe77bfeb1720
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
Department grant program.
(a) The Department of Public Health shall develop and administer the Illinois Regenerative Medicine Institute Program within the Department to provide for the awarding of grants to Illinois medical research institutions.
(b) The purposes of the Institute grant program are:
(1) to improve the health of the citizens of Illinois through stem cell research;
(2) to support scientific research in Illinois for which funding from the U.S. government is currently restricted, namely human embryonic stem cell research;
(3) to improve the national competitive position of Illinois in the field of regenerative medicine; and (4) to promote the translation of stem cell research into clinical practice and the transfer of technology to biomedical and technological industry.
(c) The Department shall adopt rules for the implementation of the Institute grant program, including but not limited to:
(1) rules for the solicitation of proposals for grants;
(2) rules concerning the eligibility of nonprofit Illinois medical research institutions to receive awards under the Institute grant program;
(3) rules for the conduct of competitive and scientific peer review of all proposals submitted under the Institute grant program;
(4) rules for the procurement of materials for the conduct of stem cell research, including rules ensuring that persons are empowered to make voluntary and informed decisions to participate or to refuse to participate in such research, and ensuring confidentiality of such decisions; and (5) rules concerning the monitoring of funded research to ensure the researcher is following current best practices with respect to medical ethics, including informed consent of patients and the protection of human subjects. (Source: P.A. 95-519, eff. 1-1-08.)